ClinicalTrials.gov
ClinicalTrials.gov Menu

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003926
Recruitment Status : Terminated (Withdrawn due to slow accrual)
First Posted : May 2, 2003
Last Update Posted : November 29, 2017
Sponsor:
Information provided by:
Masonic Cancer Center, University of Minnesota

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2002
  Actual Study Completion Date : August 2003